<DOC>
	<DOCNO>NCT02895568</DOCNO>
	<brief_summary>This study measure prevalence establish candidate molecular marker drug resistant malaria Kom√© , Doba , Republic Chad .</brief_summary>
	<brief_title>Prevalence Survey Plasmodium Falciparum Antimalarial Drug Resistance Markers</brief_title>
	<detailed_description>This cross-sectional , observational study use dry blood sample collect P. falciparum-infected individual time malaria diagnosis measure prevalence know candidate molecular marker resistance artemisinin non-artemisinin ACT partner drug . A maximum 200 participant enrol participate site per year . Study duration 2 year . Therefore total participant 400 . Prospective participant blood collect dry blood spot ( DBS ) study sample provide informed consent . Individuals confirm P. falciparum infection DBS sample include molecular analysis know candidate molecular marker antimalarial drug resistance .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Antimalarials</mesh_term>
	<criteria>Participants must meet inclusion criterion participate study . Patients ( 6 month 75 year ) confirm uncomplicated P. falciparum infection Written inform consent obtain Patients present sign severe malaria exclude survey prevent delay management patient .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Antimalarial drug</keyword>
	<keyword>Resistance</keyword>
	<keyword>Republic Chard</keyword>
</DOC>